申请人:——
公开号:US20030176503A1
公开(公告)日:2003-09-18
Thiosemicarbazone compounds of formula:
1
and pharmaceutically acceptable salts thereof are useful for treating infection by the hepatitis C virus, treating hepatitis C or a related condition, delaying the onset of hepatitis C or a related condition, preventing hepatitis C or a related condition, and inhibiting replication of the hepatitis C virus. In the formula Q is aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, cycloalkenyl, or substituted cycloalkenyl; L is absent, -alkyl-, -alkenyl-, or -alkyl-S(O)
m
-alkyl-, wherein m is an integer from zero to 2; and R
1
is —H or alkyl.
Thiosemicarbazone化合物的化学式为:
1
及其药学上可接受的盐对治疗丙型肝炎病毒感染、治疗丙型肝炎或相关疾病、延缓丙型肝炎或相关疾病的发作、预防丙型肝炎或相关疾病、以及抑制丙型肝炎病毒的复制具有用处。在该化学式中,Q代表芳基、取代芳基、环烷基、取代环烷基、环烯基或取代环烯基;L为空、-烷基-、-烯基-或-烷基-S(O)
m
-烷基-,其中m为0至2的整数;R
1
为—H或烷基。